Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Gerloni

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Drugs in Dermatology : JDD|May 30, 2019
Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In VitroCaridad Rosette, Frances J. Agan, Alessandro Mazzetti, et al.
Molecular Cancer Therapeutics|August 28, 2020
The Dual Androgen Receptor and Glucocorticoid Receptor Antagonist CB-03-10 as Potential Treatment for Tumors that have Acquired GR-mediated Resistance to AR BlockadeCaridad Rosette, Frances J Agan, Niccolette Rosette, et al.
Drug Delivery and Translational Research|February 13, 2025
A rifamycin SV in situ gelling formulation for the treatment of pouchitisKatia Mangano, Cinzia Quatrocchi, Katia Ajello, et al.
Drug Metabolism and Pharmacokinetics|May 19, 2019
Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibitionCaridad Rosette, Frances J Agan, Niccolette Rosette, et al.
International Immunology|December 28, 2002
CD4 T cell priming in dendritic cell-deficient micePaola Castiglioni, Christina Lu, David Lo, et al.
JAMA Dermatology|April 23, 2020
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical TrialsAdelaide Hebert, Diane Thiboutot, Linda Stein Gold, et al.
Vaccine|July 12, 2005
In utero DNA immunisation. Immunity over tolerance in fetal lifeMarta Rizzi, Mara Gerloni, Anand S Srivastava, et al.
DNA and Cell Biology|May 24, 2006
TLR9-independent activation of B lymphocytes by bacterial DNAXochitl Cortez-Gonzalez, Ilenia Pellicciotta, Mara Gerloni, et al.
International Journal of Antimicrobial Agents|June 13, 2013
Anti-inflammatory and immunomodulatory activities of rifamycin SVCaridad Rosette, Fernando Buendia-Laysa, Seema Patkar, et al.
European Journal of Immunology|March 5, 2003
Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virusPierre Langlade-Demoyen, Francisco Garcia-Pons, Paola Castiglioni, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Drugs in Dermatology : JDD|May 30, 2019
Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In VitroCaridad Rosette, Frances J. Agan, Alessandro Mazzetti, et al.
Molecular Cancer Therapeutics|August 28, 2020
The Dual Androgen Receptor and Glucocorticoid Receptor Antagonist CB-03-10 as Potential Treatment for Tumors that have Acquired GR-mediated Resistance to AR BlockadeCaridad Rosette, Frances J Agan, Niccolette Rosette, et al.
Drug Delivery and Translational Research|February 13, 2025
A rifamycin SV in situ gelling formulation for the treatment of pouchitisKatia Mangano, Cinzia Quatrocchi, Katia Ajello, et al.
Drug Metabolism and Pharmacokinetics|May 19, 2019
Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibitionCaridad Rosette, Frances J Agan, Niccolette Rosette, et al.
International Immunology|December 28, 2002
CD4 T cell priming in dendritic cell-deficient micePaola Castiglioni, Christina Lu, David Lo, et al.
JAMA Dermatology|April 23, 2020
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical TrialsAdelaide Hebert, Diane Thiboutot, Linda Stein Gold, et al.
Vaccine|July 12, 2005
In utero DNA immunisation. Immunity over tolerance in fetal lifeMarta Rizzi, Mara Gerloni, Anand S Srivastava, et al.
DNA and Cell Biology|May 24, 2006
TLR9-independent activation of B lymphocytes by bacterial DNAXochitl Cortez-Gonzalez, Ilenia Pellicciotta, Mara Gerloni, et al.
International Journal of Antimicrobial Agents|June 13, 2013
Anti-inflammatory and immunomodulatory activities of rifamycin SVCaridad Rosette, Fernando Buendia-Laysa, Seema Patkar, et al.
European Journal of Immunology|March 5, 2003
Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virusPierre Langlade-Demoyen, Francisco Garcia-Pons, Paola Castiglioni, et al.
Pageof 3